Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xzōm
San Diego, California, United States
- Ownership
- Private
- Employees
- ~35
- Development stage
- Other
01
Overview
Xzōm is developing a proprietary point-of-care liquid biopsy platform that uses on-chip exosome analysis to deliver clinical-grade diagnostic results in 30 minutes or less. The technology is designed for rapid, near-patient testing and aims to enable earlier detection of cancer, neurological disorders, infectious diseases, and more. The company’s mission is to make early disease detection accessible and affordable globally by shifting healthcare from reactive intervention to proactive diagnosis. As of June 2025, the lead product is in development with an anticipated seed round closing in July 2025.
- Therapeutic areas
- Infectious DiseasesNeurologyOncology
- Modalities
- Exosome-based diagnosticsLiquid biopsy platform
- Industry
- Molecular Diagnostics
02
Partnerships
No major pharmaceutical or biotech partnerships publicly disclosed as of June 2025.
Beyond the preview
Go deeper on Xzōm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xzōm.